Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study

Background Identifying the risk of psoriasis relapse after discontinuing biologics can help optimize treatment strategies, potentially reducing relapse rates and alleviating the burden of disease management.